A pharmacist fact sheet has been published by the Health Department in relation to the 01 Dec changes to encourage the use of biosimilar brands of biological medicines.
Brenzys (etanercept) is a biosimilar for Enbrel and there is a new administrative note for prescribers in the Schedule of Pharmaceutical Benefits encouraging its use - more info at www.pbs.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 04 Dec 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Dec 17
